Maryann Gallagher

3.6k total citations
41 papers, 2.8k citations indexed

About

Maryann Gallagher is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Maryann Gallagher has authored 41 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Maryann Gallagher's work include Advanced Breast Cancer Therapies (14 papers), Cancer-related Molecular Pathways (8 papers) and Cancer Treatment and Pharmacology (8 papers). Maryann Gallagher is often cited by papers focused on Advanced Breast Cancer Therapies (14 papers), Cancer-related Molecular Pathways (8 papers) and Cancer Treatment and Pharmacology (8 papers). Maryann Gallagher collaborates with scholars based in United States, Spain and United Kingdom. Maryann Gallagher's co-authors include Peter J. O’Dwyer, George Preti, James Stevenson, Keith T. Flaherty, Mark Rosen, Xiang Sun, Charles J. Wysocki, Andrew Spielman, William D. James and David J. Vaughn and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Maryann Gallagher

40 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maryann Gallagher United States 22 1.1k 1.0k 687 405 316 41 2.8k
Rongcheng Luo China 35 1.1k 1.0× 2.4k 2.4× 686 1.0× 502 1.2× 260 0.8× 207 4.2k
Angel L. Armesilla United Kingdom 30 507 0.5× 1.6k 1.6× 118 0.2× 286 0.7× 188 0.6× 50 2.8k
Nelson S. Yee United States 30 780 0.7× 1.2k 1.2× 308 0.4× 526 1.3× 75 0.2× 83 3.0k
Somaira Nowsheen United States 37 1.3k 1.2× 2.1k 2.0× 357 0.5× 341 0.8× 93 0.3× 74 3.2k
Miguel Izquierdo Spain 29 2.3k 2.1× 1.4k 1.3× 777 1.1× 137 0.3× 41 0.1× 80 3.9k
Nayiyuan Wu China 24 742 0.7× 1.7k 1.7× 557 0.8× 426 1.1× 123 0.4× 84 2.9k
Chao Chen China 29 817 0.7× 1.4k 1.3× 320 0.5× 427 1.1× 113 0.4× 130 2.7k
Gang Yang China 30 1.5k 1.3× 1.8k 1.8× 469 0.7× 535 1.3× 200 0.6× 79 3.4k
Peng Hou China 41 1.3k 1.2× 3.3k 3.2× 618 0.9× 429 1.1× 264 0.8× 177 5.7k
Lin Zhao China 38 926 0.8× 2.6k 2.5× 579 0.8× 731 1.8× 212 0.7× 148 4.3k

Countries citing papers authored by Maryann Gallagher

Since Specialization
Citations

This map shows the geographic impact of Maryann Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryann Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryann Gallagher more than expected).

Fields of papers citing papers by Maryann Gallagher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryann Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryann Gallagher. The network helps show where Maryann Gallagher may publish in the future.

Co-authorship network of co-authors of Maryann Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of Maryann Gallagher. A scholar is included among the top collaborators of Maryann Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryann Gallagher. Maryann Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clark, Amy S., Nicholas P. McAndrew, Andrea B. Troxel, et al.. (2019). Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer. Clinical Cancer Research. 25(7). 2072–2079. 35 indexed citations
2.
Narayan, Vivek, Wei‐Ting Hwang, Priti Lal, et al.. (2016). Cyclin-Dependent Kinase 4/6 Inhibition for the Treatment of Unresectable Mature Teratoma: Long-Term Follow-Up of a Phase II Study. Clinical Genitourinary Cancer. 14(6). 504–510. 25 indexed citations
3.
Clark, Amy S., Thomas B. Karasic, Angela DeMichele, et al.. (2015). Palbociclib (PD0332991)—a Selective and Potent Cyclin-Dependent Kinase Inhibitor. JAMA Oncology. 2(2). 253–253. 95 indexed citations
4.
DeMichele, Angela, Amy S. Clark, Kay See Tan, et al.. (2014). CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment. Clinical Cancer Research. 21(5). 995–1001. 280 indexed citations
5.
Rangwala, Reshma, Robert D. Leone, Yunyoung C Chang, et al.. (2014). Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy. 10(8). 1369–1379. 294 indexed citations
6.
Coats, Caroline, Maryann Gallagher, Michael Foley, et al.. (2013). Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy. European Heart Journal. 34(32). 2529–2537. 85 indexed citations
7.
Lal, Priti, Michael D. Feldman, Maryann Gallagher, et al.. (2013). Abstract P2-16-20: Biomarkers to predict response to the CDK 4/6 inhibitor, palbociclib (PD 0332991) in a single-agent phase II trial in advanced breast cancer. Cancer Research. 73(24_Supplement). P2–16. 3 indexed citations
8.
Sun, Weijing, James M. Metz, Maryann Gallagher, et al.. (2010). Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas. Cancer Chemotherapy and Pharmacology. 67(3). 621–627. 4 indexed citations
9.
Gallagher, Maryann, et al.. (2008). Synergistic Mixture Interactions in Detection of Perithreshold Odors by Humans. Chemical Senses. 33(4). 363–369. 70 indexed citations
10.
Gallagher, Maryann, Charles J. Wysocki, William D. James, et al.. (2008). Analyses of volatile organic compounds from human skin. British Journal of Dermatology. 159(4). 780–791. 333 indexed citations
11.
Vonderheide, Robert H., Keith T. Flaherty, Magi Khalil, et al.. (2007). Clinical Activity and Immune Modulation in Cancer Patients Treated With CP-870,893, a Novel CD40 Agonist Monoclonal Antibody. Journal of Clinical Oncology. 25(7). 876–883. 416 indexed citations
12.
Wise, Paul M., et al.. (2007). Human Odor Detection of Homologous Carboxylic Acids and Their Binary Mixtures. Chemical Senses. 32(5). 475–482. 29 indexed citations
13.
Veronese, Maria Luisa, Ari Mosenkis, Keith T. Flaherty, et al.. (2006). Mechanisms of Hypertension Associated With BAY 43-9006. Journal of Clinical Oncology. 24(9). 1363–1369. 256 indexed citations
14.
Veronese, M L, K. T. Flaherty, Raymond R. Townsend, et al.. (2004). Pharmacodynamic study of the raf kinase inhibitor BAY 43–9006: Mechanisms of hypertension. Journal of Clinical Oncology. 22(14_suppl). 2035–2035. 1 indexed citations
15.
Sun, Weijing, Richard Whittington, Maryann Gallagher, et al.. (2004). Concurrent RT with 5-FU/epirubicin and cisplatin or irinotecan for locally advanced upper GI adenocarcinoma.. PubMed. 18(14 Suppl 14). 39–42. 2 indexed citations
16.
Flaherty, Keith T., James Stevenson, Maryann Gallagher, et al.. (2003). Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer. Cancer. 97(8). 1985–1990. 5 indexed citations
17.
Stevenson, James, Mark Rosen, Weijing Sun, et al.. (2003). Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood Flow. Journal of Clinical Oncology. 21(23). 4428–4438. 251 indexed citations
18.
Sun, Weijing, James Stevenson, Maryann Gallagher, et al.. (2001). A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors. Cancer. 92(2). 414–419. 21 indexed citations
19.
Xu, Jiake, et al.. (1993). Peptide splicing in the vacuolar ATPase subunit A from Candida tropicalis.. Journal of Biological Chemistry. 268(10). 7372–7381. 49 indexed citations
20.
Gallagher, Maryann, et al.. (1990). Gene and derived peptide sequences forC.tropicalisvacuolar ATPase subunit b. Nucleic Acids Research. 18(24). 7446–7446. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rongcheng Luo Breakdown of academic impact, for papers by Angel L. Armesilla Breakdown of academic impact, for papers by Nelson S. Yee Breakdown of academic impact, for papers by Somaira Nowsheen Breakdown of academic impact, for papers by Miguel Izquierdo Breakdown of academic impact, for papers by Nayiyuan Wu Breakdown of academic impact, for papers by Chao Chen Breakdown of academic impact, for papers by Gang Yang Breakdown of academic impact, for papers by Peng Hou Breakdown of academic impact, for papers by Lin Zhao
Rankless by CCL
2026